Human Rotavirus antigen (HRV antigen) (HRV antigen)

Human Rotavirus antigens are the protein components of the Rotavirus, a member of the Reoviridae family and the most common cause of severe diarrheal disease in children globally (CDC, 2023; StatPearls, 2023). The virus consists of a triple-layered capsid, with the outermost layer composed of the antigens VP7 (a glycoprotein) and VP4 (a protease-sensitive protein), which are the primary targets for neutralizing antibodies (Desselberger, 2014). These antigens facilitate the virus's attachment to and penetration of host enterocytes in the small intestine, leading to malabsorption and secretory diarrhea (Greenberg & Estes, 2009). Therapeutic strategies primarily focus on prevention through live-attenuated vaccines, such as Rotarix and RotaTeq, which expose the host immune system to these antigens to elicit a protective IgA response (WHO, 2021). Additionally, these antigens serve as the primary diagnostic markers in enzyme-linked immunosorbent assays (ELISA) and rapid immunochromatographic tests used to confirm infection in clinical settings (StatPearls, 2023). The VP6 protein, located in the middle capsid layer, is highly conserved and is the most common target for diagnostic antigen detection (Desselberger, 2014). Understanding the antigenic diversity of VP7 and VP4 is essential for monitoring vaccine efficacy against various circulating strains (WHO, 2021).

Other names

Rotavirus A antigenRotavirus structural proteinVP7 glycoproteinVP4 protease-cleaved proteinVP6 inner capsid proteinRotavirus capsid antigen

Vaccines containing these antigens induce the production of neutralizing antibodies (primarily secretory IgA) that block viral attachment and entry into intestinal enterocytes, thereby preventing infection and severe disease (Greenberg & Estes, 2009; WHO, 2021).